Behcet's syndrome: prevalence of clinical characteristics in three countries (Turkey, United States and the Netherlands)

Recruiting

• Conditions: Behcet Syndrome; 10003816

• Registration Number: NL-OMON33363
• Lead Sponsor: Investigator driven onderzoek, Prof B.A.C Dijkmans is hoofd van onze groep

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 50

Inclusion Criteria

Adult patients who fullfill the international criteria of Behcet syndrome

Exclusion Criteria

none

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Clinical outcome measures: activity according to the current activity form<br /><br>Prevalence of the different organ involvement<br /><br>comparing western with non-western<br /><br><br /><br>For example:<br /><br>percentage of patients with uveitis<br /><br>percentage of patients with complete blindness due to uveitis<br /><br>percentage of patients with diminished visus due to the uveitis<br /><br>comparing the prevalence between the patients in the Nederland, United States<br /><br>and Turkey, also comparing western (NL and US) versus non-western (Turkey)</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>not applicable</p><br>